36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Keyphrases

• 12-month Follow-up 14%
• All-cause Mortality 28%
• Anticoagulant Therapy 14%
• Anticoagulation 28%
• Cause of Death 14%
• Clinical Outcomes 100%
• Confidence Interval 14%
• Deep Vein Thrombosis 71%
• GARFIELD 100%
• Global Perspective 14%
• January 2017 14%
• Major Bleed 14%
• Major Bleeding 14%
• Non-interventional 14%
• Oral Anticoagulants 57%
• Parenteral Therapy 28%
• Patient Demographics 14%
• Patient Outcomes 14%
• Pulmonary Embolism 57%
• Recurrent Venous Thromboembolism 42%
• Treatment Gap 14%
• Treatment Practices 14%
• Venous Thromboembolic Events 14%
• Venous Thromboembolism 100%

Medicine and Dentistry

• All Cause Mortality 20%
• Anticoagulant Therapy 10%
• Anticoagulation 20%
• Antithrombotic 40%
• Ciclonicate 10%
• Deep Vein Thrombosis 50%
• Major Bleeding 10%
• Malignant Neoplasm 10%
• Observational Study 10%
• Parenteral Drug Administration 20%
• Patient Population 10%
• Pulmonary Embolism 40%
• Venous Thromboembolism 100%

Pharmacology, Toxicology and Pharmaceutical Science

• All Cause Mortality 20%
• Anticoagulant Agent 40%
• Anticoagulation Therapy 10%
• Bleeding 10%
• Ciclonicate 10%
• Deep Vein Thrombosis 50%
• Lung Embolism 40%
• Malignant Neoplasm 10%
• Observational Study 10%
• Venous Thromboembolism 100%